PetMed Express, Inc. 

(Public, NASDAQ:PETS)   Watch this stock   
Find more results for PETS
Oct 19, 2009
Q2 2009 Earnings Conference Call
Oct 19, 2009
Q2 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 10.03% 10.47%
Operating margin 15.74% 15.59%
EBITD margin - 15.96%
Return on average assets 25.42% 29.57%
Return on average equity 29.18% 32.36%
Employees 248 -

Address

1441 S.W. 29th Avenue
Pompano Beach, FL 33069
United States - Map
+1-954-9795995 (Phone)
+1-954-9710544 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

PetMed Express, Inc. discussed on blogs

Ranking 1300+ Small Cap Stocks by Cash Flow Per Share - NASD100 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 1 hour ago

PetMed Express, Inc. discussions

  View all discussions »

Description

PetMed Express, Inc. (PetMed) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses direct to the consumer. The Company markets its products through national television, online, and direct mail/print advertising campaigns. PetMed offers a selection of products for dogs, cats, and horses. As of March 31, 2009, its product line contains approximately 750 stock keeping units (skus). These products include brands of medication, such as Frontline Plus, K9 Advantix, Advantage, Heartgard Plus, Sentinel, Interceptor, Program, Revolution, Deramaxx and Rimadyl.

Officers and directors

Robert C. Schweitzer
Chairman of the Board
Age: 63
Bio & Compensation - Reuters
Menderes Akdag
President, Chief Executive Officer, Director
Age: 48
Bio & Compensation - Reuters
Bruce S. Rosenbloom
Chief Financial Officer
Age: 40
Bio & Compensation - Reuters
Ronald J. Korn
Director
Age: 69
Bio & Compensation - Reuters
Gian M. Fulgoni
Director
Age: 61
Bio & Compensation - Reuters
Frank J. Formica
Director
Age: 65
Bio & Compensation - Reuters